Introduction
The advent of novel sequencing technologies has revealed that less than 2% of the human genome encodes for proteins [1] [2] [3] . Interestingly, despite not being translated into proteins, a large fraction of the mammalian genome is transcribed into what is known as non-coding RNAs (ncRNAs) [1] [2] [3] . The consistent observation of pervasive transcription originating from these noncoding sites suggests that ncRNAs might play a key role in fundamental biological functions [1] [2] [3] .
To date, thousands of ncRNAs have been putatively described. Yet, the precise functional roles of the vast majority remain unclear [4] [5] [6] .
Among the different classes of ncRNAs, long non-coding RNAs (lncRNAs), broadly defined as those non-coding transcripts larger than 200 nucleotides 1 , represent one of the largest and least understood nucleic acid molecules in vertebrates. Overall, more than 9,000 genomic loci are predicted to code for these transcript subclasses in the human genome 5, 7, 8 . Recent reports describing important developmental roles for certain lncRNAs in various vertebrates have appeared over the last few years [9] [10] [11] . Low expression levels and poor sequence conservation have limited the identification and functional characterization of novel lncRNAs 12 . Combining novel sequencing and analytical technologies with the powerful platforms that pluripotent stem cell (PSC) models provide for the study of human embryonic development, these limitations can now be circumvented.
By using a methodology recently developed in our laboratory that allows for the highly efficient generation of human cardiovascular progenitor cells of mesodermal origin and terminally differentiated vascular endothelial cells 13 , here we report on the identification and functional characterization of three novel human lncRNAs indispensable for the development of the cardiovascular system in different vertebrate species.
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Materials and methods

Cell culture
Human Embryonic Stem Cells (hESCs), H1 (WA1, WiCell) (passage [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] were used for differentiation studies. Terminally differentiated primary Human Umbilical Vein Endothelial Cells (HUVECs) were used to investigate the transcriptome and functional roles of lncRNAs candidates in unmodified vascular endothelial cells. Briefly, hESCs were cultured in chemically defined growth media, mTeSR (StemCell technologies), on growth factor reduced matrigel (BD biosciences) coated plates. 70-80% confluent hESCs were treated with dispase (Invitrogen) for 7 minutes at 37°C and the colonies were dispersed to small clusters and lifted carefully using a 5ml
glass pipette, at a ratio of ~1:6. HUVECs were purchased from Promocell and cultured in Endothelial Basal Medium (EBM) supplemented with Endothelial Growth Medium (EGM) singlequots (Lonza). hESC-derived endothelial cells were cultivated in EGM-2 bullet kit media (Lonza). Endothelial cells were grown on collagen I coated plates (BD biosciences). All cell lines were maintained in an incubator (37°C, 5% CO2) with media changes every day (hESCs) or every second day (HUVEC).
Cell lineages analyzed
Pluripotent stem cells were differentiated into early mesoderm-derived cells including c-Kit+ and KDR+ cardiovascular progenitors (day 2 to day 4 of differentiation) and committed CD34+CD31+ bi-potent vascular progenitor cells (day 4 to day 8 of differentiation) as previously described (please refer to reference 13 by Kurian et al., for detailed characterization of the differentiation methodologies and cell types generated). Terminally differentiated primary
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early cardiovascular progenitors (day 2 to day 4) and committed vascular progenitor cells (day 4 to day 8) undifferentiated hESCs were freshly split on to matrigel-coated plates, making sure the sub-colonies were of small size (~300-500 cells/colony). Cells were differentiated to different progenitor stages using a chemically defined mesodermal induction media (MIM) as previously described 13 (DMEM:F12, 15mg/ml stem cell grade BSA (MP biomedicals), 17.5μg/ml Human Insulin (SAFC bioscience), 275μg/ml Human holo transferrin (Sigma Aldrich), 20ng/ml bFGF (Humanzyme), 50ng/ml Human VEGF-165 aa (Humanzyme), 25ng/ml human BMP4
(Stemgent), 450μM monothioglycerol (Sigma Aldrich), 2.25mM each L-Glutamine and Nonessential amino acids (Invitrogen). Switching day 8 MIM-differentiated cells to EGM2 media as described 13 induced endothelial cell differentiation. HUVEC cells are of primary origin and were therefore not modified during our studies.
RNA-sequencing
Total RNA from roughly 1x10 7 cells of each of the above-indicated groups was isolated with TRIzol (Invitrogen). Intact total RNA samples were treated with DNase1 and sent to the Beijing Genomics Institute (BGI) for sequencing. Prior to sequencing, all samples were subjected to quality control processes to ensure the lack of contaminating DNA and integrity of the RNA. All the RNA samples met the following RNA quality threshold-OD260/280 = 2-2.2; OD260/230 2.0; 28S:18S> 1.0, RIN>7. Whole transcriptome sequencing was then performed. Briefly, TruSeq Stranded Total RNA with Ribo-Zero Human kit (Illumina) was used to remove ribosomal RNA and prepare strand specific paired end RNA seq libraries. 90 million 2x 100 bp paired end reads were sequenced on an Illumina HiSeq2000 instrument for each library. Reads were aligned to the hg19/GRCh37 version of the human genome by using STAR (v2.1.4a). Only reads that aligned to a single unique location were kept for further analysis. Quantification of described 13 induced endothelial cell differentiation. HUVEC cells are of primary ori rigi i gin n an and d we w re f herefore not modified during our studies.
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Primers used in this study
Please refer to Table 1 in the online-only Data Supplement for a list of primers and their respective sequences.
Morpholino embryo injections
Morpholinos (Gene Tools) were designed against highly conserved regions in the lncRNAs, or alternatively to block putative splice sites ( Table 2 in the online-only Data Supplement). A pair
of morpholinos was generated and tested per lncRNA. For zebrafish injection, morpholinos were dissolved in water at a 2mM stock concentration and diluted to a 2ng/nl working concentration in PBS/phenol red solution. Embryo injections were performed by injecting ~1nl morpholino solution at the 1-cell stage using a FemtoJet (Eppendorf). Morphants were evaluated at 24, 48, 72
and 96 hours in a StereoLumar stereoscope (Zeiss). For murine experiments, CD-1 female mice were superovulated by injecting pregnant mares serum gonadotropin (PMSG) followed by human chorionic gonadotropin (hCG) 48 hours later. The female mice were housed with males after hCG injection. 1-cell stage embryos were collected the next day after 20 hours and were injected with 10pl of 2nM stock Terminator morpholino using a FemtoJet. The embryos were cultured until the blastocyst stage in K-modified simplex optimized medium (KSOM) and RNA was extracted using RNeasy mini kit (Qiagen).
Data availability
All datasets in this study are available in the NCBI Gene Expression Omnibus under the following accession number: GSE54969.
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cells (day 8, CD34+CD31+
) and vascular endothelial cells (VE-Cadherin+Endoglin+) (please refer to Kurian et al. 13 for detailed characterization of the generated cell lineages) ( Figure 1A in the online-only Data Supplement). After ribosomal RNA depletion and size removal of species whose length was smaller than 150 nucleotides, we generated datasets with a sequencing depth of 90 million paired end reads of 100 base pairs per sample (Figure 1A,B; Figure 2B ,C and 13 . In order to describe the global transcriptomic changes across the genome we investigated the genomic coverage of RNA-seq data (at least one read), all different cell types indicated that ~56% of the genome was transcriptionally activated during vascular progenitor cell differentiation [14] [15] [16] [17] ( Figure After excluding repetitive sequences, we identified a total of 406 novel transcripts that were not annotated previously in any database (83 were promoter anti-sense, 188 were intergenic and 135
were anti-sense gene sequences) [14] [15] [16] [17] . By considering both, annotated and non-annotated transcripts, we observed that one of the largest groups differentially regulated during differentiation was that of lncRNAs (~1924). These observations therefore suggest that lncRNAs have a functional involvement during mesoderm development and cell fate specification 5, 9, 10, 18 .
of differentiation as well as committed vascular progenitor cells (day 4 to 8) 13 . In n ord r er er e t to o describe the global transcriptomic changes across the genome we investigated the genomic previous reports and further demonstrate that early cardiac and vascular developmental programs share common genetic pathways prior to further cell type specification in humans 21, 22 . Chromatin modification analysis identified an increasing number of bivalent sites as differentiation progressed, for both protein-coding as well as for lncRNA sites ( Figure 1E and Figure 2D in the online-only Data Supplement). Differentiation to endothelial cells resulted in the up-regulation of >1000 genes and the downregulation of ~2500 genes ( Figure 1B) . Genome-wide methylation profiling highlighted significant hypomethylation at lncRNA sites (19%, Figure 2E in the online-only Data Supplement). Together, these results suggested an important regulatory role for lncRNAs during lineage specification (as compared to, for example, 5% for microRNAs, Figure   2E in the online-only Data Supplement). hare common on g gen enet etic ic p p pathw hway ay a s s pr prio ior to to to f fu urt rthe he er r r ce ce c ll ll l t typ yp pe e e sp sp pec ecif ific i at t atio io on n in in in h hum um u an an a s s 21 21,22 22 . Chromatin n
Identification of non-coding RNAs differentially regulated during human Pluripotent Stem
Cell differentiation to vascular endothelial cells.
To identify enriched DNA motifs acting as regulatory elements, we made use of HOMER, an analytical tool suitable for promoter enrichment analyses 15 . Promoter motif enrichment (-300, . We next employed a stringent fivestep filtering process at each indicated differentiation stage to identify novel lncRNAs, whose Figure 1F ). Interestingly, lncRNAs comprised the largest class of non-cod din ng g tr tr t an ansc scri ripts ubjected to strict temporal regulation patterns during differentiation. These results are in line with h t t the he n not otio io i n th th ha at lncRNAs are more tightly co ont n n r rolled in terms s of tim m mi in i g and cell type p pec cificity than p p pro otei in-n-n co co codi di d ng ng n tra a ans ns n cr rip i ts 18, 8,23 2 . . We e e t then n n s sele e ect cted 4 4 disti tinc c ct gr gr ro o oups s of f f ln lncR R RNA NA As, s, well-defined promoters, exon-intron structure codon conservation and ribosomal footprints, among others), as well as a lack of coding potential 6, 24 . None of these transcripts possessed coding potential, as determined by GeneID analysis 24 ( Figure 3C in the online-only Data Supplement), as well as a lack of identifiable amino acid domains and lack of codon conservation across evolution or ribosomal footprints (data not shown).
Characterization of three novel lncRNAs differentially expressed during endothelial cell differentiation.
Next, we sought to determine the functionality of the three different lncRNAs selected. To do so, tructure, partial sequence conservation across vertebrates) and at least one of the e lat a te e er r (e (e.g .g. . E EST data in lower vertebrates). Next, we randomly selected three previously uncharacterized Figure 4C and Table 4 
Novel lncRNAs functionally control pluripotency, cardiovascular commitment and endothelial cell identity.
In order to gain insights into the physiological relevance of the identified lncRNAs, we first evaluated their expression pattern during mouse and zebrafish embryonic development. In accordance with their expression during human vascular differentiation, Terminator expression was maximal at the blastocyst stage in mouse and at 6 hours post-fertilization (hpf) in zebrafish, closely correlating with the expression of Pou5f1 (Oct4) and Nanog ( Figure 3A and Figure 2C and Figure 5 in the online-only Data Supplement). terminator levels were undetectable in 1-cell stage zebrafish embryos immediately after fertilization, suggesting that Terminator was not already present in the oocyte prior to fertilization ( Figure 3A) . Alien was expressed in the correlated with PUNISHER ( Figure 2D ). Together, these results indicate a stage--sp pec cif ific ic function for each of the different lncRNAs in regulating gene expression. Additionally, none of he id id den en e ti tifi fied ed d lnc c cRN RN R As were physically associate ted d t to polypeptide es s of th th he e ribosome translational m mac chinery. Thus s, s t thi is co co onf nf fir irms ms m the he e n non n n-cod di ing g na at a u ure of of f th he e s sele ec ct ted tr ran an nsc cr ri rip pt p s. Figure 3D and Table 5 in the online-only Data Supplement). Additionally, as previously mentioned, there were described ESTs transcribed from the conserved loci in mouse as well as in zebrafish. TERMINATOR was found to be an intergenic lncRNA located next to ZNF281 in human and mouse (in both cases in chromosome 1). It presents H3K27Ac sites in start and end regions (marking actively transcribed chromatin) and its genomic location is conserved in sense. ALIEN represents a subclass of lncRNAs, a lincRNA (long interspersed non-coding RNA). It was found located in an intergenic region with low gene density. It is encoded in sense with exons and its location is conserved next to FOXA2 in mouse, human and zebrafish. Last, PUNISHER was found to be an antisense lncRNA covering exonic and intronic sequences of the AGAP2 gene. Its location is conserved in mouse and human and it is transcribed as an antisense to AGAP2 and it presents H3K27Ac sites.
Taken together, our results indicate that these three lncRNAs are conserved from zebrafish to human, and show similar stage-specific expression during development. Figures 7B,C) . PUNISHER knockdown also impaired acetyl-LDL uptake, a hallmark of endothelial cell functionality, therefore indicating severely impaired endothelial cell function as compared to scrambled shRNA controls and unmodified endothelial cells ( Figure 7D ).
Discussion
Recent discoveries indicating that the mammalian transcriptome is comprised of a large majority of non-coding transcripts (~60%) as opposed to coding RNAs (~7%) have brought about the question as to whether non-coding sequences can play a role in controlling cellular fate and functionality, ultimately affecting biological diversity 25, [32] [33] [34] . Despite major efforts, little information is available regarding the actual cellular functions of ncRNAs in the context of human development, physiology and disease 9, 10, 19, 35, 36 . Among the existing information, lncRNAs identified in pluripotent cells have been mainly ascribed to gene-network interactions, regulation of chromatin and the control of the pluripotency network 19, 33, 35 . Similarly, other recent reports have focused on the identification of lncRNAs during cardiomyocyte generation and identified Braveheart and Fenderr as critical players during the development of the early cardiovascular system and ultimately, the murine heart 9,10 .
Pluripotent cell differentiation has been demonstrated to be a suitable platform for recapitulating key developmental stages in a dish, as well as for the establishment of cellular
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